Log in or Sign up for Free to view tailored content for your specialty!
Rheumatoid Arthritis News
Though still used, glucocorticoid treatments ‘should be avoided’ in patients with RA
Glucocorticoids are still one of the most commonly used treatments for rheumatoid arthritis, with an estimated up to 50% of patients with RA in the United States using them long-term as of 2021.
United Rheumatology, CreakyJoints launch RA resource during Arthritis Awareness Month
United Rheumatology and CreakyJoints have announced a partnership to launch the Rheumatoid Arthritis Wellness Center, a digital resource that aims to offer support to patients living with RA, according to a press release.
Log in or Sign up for Free to view tailored content for your specialty!
‘Risk averse’ rheumatologists report declining JAK use, increased reliance on abatacept
The safety signals for cardiovascular events and malignancy associated with Janus kinase inhibitors in rheumatoid arthritis have led to rheumatologists increasingly reaching for abatacept instead, according to data.
‘More work to be done’: DMARD use remains low in older adults with rheumatoid arthritis
Despite guidelines recommending early and aggressive therapy in rheumatoid arthritis, disease-modifying antirheumatic drug adoption for older patients remains low, according to data published in ACR Open Rheumatology.
Nurse-led education prevents adverse effects in rheumatoid arthritis, SpA treatment
Nurse-led education for patients with rheumatoid arthritis or spondyloarthritis, who are beginning biologic disease-modifying antirheumatic drugs, is effective at changing behaviors to prevent adverse events, according to data.
Influenza vaccine uptake ‘suboptimal’ in adults with early rheumatoid arthritis
Influenza vaccination coverage in adults with early rheumatoid arthritis in Canada remains “suboptimal,” according to data published in ACR Open Rheumatology.
New drugs, new guidelines: ACR/AAHKS update treatment recommendations in joint replacement
Joint replacement in patients with inflammatory arthritis is often beset with pitfalls like disease flares and infectious complications, and up until recently, the emergence new treatments were rendering the current guidelines outdated.
Upcoming biosimilar logjam could provide cost savings for arthritis drugs
The upcoming influx of new biosimilar drugs to the market could mitigate the cost of biologics to treat inflammatory diseases, said Steven Newmark, director of policy and chief legal officer for the Global Healthy Living Foundation.
Frailty common in rheumatoid arthritis, predicts mortality, hospitalization
Frailty is common in patients with early and established rheumatoid arthritis, is potentially responsive to early treatment, and predicts all-cause mortality and hospitalization, according to data published in RMD Open.
Long-term air pollution exposure increases autoimmune disease risk
Patients who face long-term exposure to air pollution demonstrate a higher risk for developing autoimmune diseases, including rheumatoid arthritis, according to data published in Rheumatic and Musculoskeletal Diseases.
-
Headline News
We must make our voices heard and vote in the 2024 election
September 18, 20247 min read -
Headline News
Semaglutide improves glucose control in automated insulin delivery for type 1 diabetes
September 20, 20243 min read -
Headline News
Oncologists, primary care clinicians should be aware of BRCA testing indications in men
September 19, 20244 min read
-
Headline News
We must make our voices heard and vote in the 2024 election
September 18, 20247 min read -
Headline News
Semaglutide improves glucose control in automated insulin delivery for type 1 diabetes
September 20, 20243 min read -
Headline News
Oncologists, primary care clinicians should be aware of BRCA testing indications in men
September 19, 20244 min read